Assessment of BRAF V600E (VE1) immunochemistry for the detection of BRAF V600E mutation in non–small cell lung carcinoma cytology specimens
Sign Up to like & getrecommendations! Published in 2022 at "Cancer Cytopathology"
DOI: 10.1002/cncy.22648
Abstract: Non–small cell lung carcinoma (NSCLC) patients with BRAF V600E–mutated tumors respond to targeted therapy. Testing for BRAF V600E is commonly performed with molecular methods; however, a mutation‐specific VE1 antibody clone can provide an alternative testing… read more here.
Keywords: ve1; immunochemistry; braf v600e; cytology ... See more keywords